Share this
realizing the promise of personalized medicine
by Neoteryx Microsampling on Feb 9, 2019 2:10:00 PM
One area that has brought significant shifts in the field of healthcare is personalized medicine. The tools, techniques, and technology of personalized medicine, along with the larger ideas that drive them, have enabled many healthcare providers to categorize patients into small groups depending on specific similarities. These similarities include patients’ DNA, lifestyles, and environments.
Big personalized medicine innovations are swiftly shifting from their early promise into reality. Here are some key areas to watch as translational research delivers returns in clinical care settings.
New Pathways of Medical Delivery
In new, more sophisticated approaches to delivery of care, patients are more involved in their treatment regimens in a collaborative and transparent manner. They may use remote devices at home to track their own conditions and collect their own specimen samples, which actively engages them in self-managing their health. The samples may be sent to the lab for analysis, and data from remote devices or samples may be transmitted electronically through secure digital systems. Such approaches create better relations between patients and doctors.
This trend has been boosted by the rise of remote patient monitoring, which involves technologies that enable doctors to electronically access information about their patients. If a doctor decides to change a patient's medication, they can submit the new prescription digitally to the pharmacy. The patients can also use online platforms or digital apps to order drug refills or new prescriptions for delivery to their home. Changes can be communicated digitally as well, with doctors scheduling telehealth consultations with their patients, and using phone, email and video chat for those virtual appointments.
Genomics
The study of human genes by health experts has also played a great role in making personalized medicine a reality. Scientists are able to use genetic information obtained from various research studies to better determine the likelihood of a person manifesting a genetically inherited illness, and the potential effects of that illness. This data is useful in developing medications that might prevent symptoms and effects, or in developing better treatments targeted to specific patients based on their genetic makeup. For example, if an individual has a certain biomarker of a disease, they would receive the medication most effective for that particular biomarker. This genetic approach not only improves the accuracy of diagnosis, but also reduces the cost and potential side effects of trial-and-error treatments with less targeted medications.
Biosensors and Telemedicine
Development of information technology is proving to be a breakthrough in improving patient monitoring. This has made the management of chronic conditions easier for patients and doctors. Patients are able to use biosensors to monitor their own disease progress for conditions such as diabetes, cancer, and cardiovascular disease. They are able to send their monitoring data and other details to their doctors digitally via smartphones or computers without necessarily going to the clinic in person. Telemedicine can occur in real time without the hindrances or delays encountered in traditional medicine that involves delayed appointment scheduling and follow-up visits.
Microsampling
The proliferation of remote specimen collection and microsampling methods are proving influential in improving personalized medicine and patient monitoring. Patients are able to perform remote sample collection using microsampling devices. Such devices enable the collection of small volumes of bio-fluid that are more precise. Allowing people to collect their own specimen samples at home and send them to a centralized lab for analysis actively involves them in their own treatment, and enables more patient-centered clinical care.
With remote and digital technologies, there is no doubt that the state of personalized medicine is able to shift from its promises to reality. There is great potential to develop related methods and technologies even more the in future.
Share this
- Microsampling (206)
- Research, Remote Research (118)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (73)
- Therapeutic Drug Monitoring, TDM (50)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (19)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Pharmaceuticals, Drug Development (9)
- Harpera® Tool (7)
- Skin Microsampling, Microbiopsy (6)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think